Global Bovine Respiratory Disease Treatment to Grow at a CAGR of 8.11% by 2021 - Growing Focus on the Development of Combination Drugs - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Bovine Respiratory Disease Treatment 2017-2021" report to their offering.

The global bovine respiratory disease treatment to grow at a CAGR of 8.11% during the period 2017-2021.

The report, Global Bovine Respiratory Disease Treatment 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is growing focus on the development of combination drugs. There has been a growing focus of vendors to develop combination drugs that can offer improved efficacy and better treatment outcomes. Traditionally, many drugs have been developed for the treatment of BRD. However, those drugs have been associated with many unmet medical needs. The current treatment options cannot treat the disease completely as BRD is associated with complex etiology.

According to the report, one of the major drivers for this market is development of novel products. The development of novel products is expected to bring substantial growth opportunities in the market. The launch of new products will substantially increase the adoption rates, thereby driving the market growth. Traditionally, antibiotics and vaccines are typically used for the treatment of BRD. To gain competitive advantage, vendors are focusing on developing novel drugs to drive growth and profitability substantially.

Key vendors

  • Bayer HealthCare
  • Boehringer Ingelheim
  • Elanco
  • Merck
  • Zoetis

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: An overview of bovine respiratory disease

PART 06: Market landscape

PART 07: Market segmentation by product category

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

PART 14: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/2kc83r/global_bovine

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs